Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness and Safety of Telmisartan in Acute Respiratory Failure Due to COVID-19

NCT04510662 is registered in ClinicalTrials.gov with Abraham Edgar Gracia-Ramos as lead sponsor.

NCT NCT04510662
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04510662 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness and Safety of Telmisartan in Acute Respiratory Failure Due to COVID-19
Lead sponsor
Abraham Edgar Gracia-Ramos
Phase
Phase 2
Overall status
Completed
Start date
August 12, 2020
Completion date
May 25, 2021
Enrollment
66 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, respiratory distress syndrome, adult, respiratory insufficiency, telmisartan